Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02129062 |
Title | Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | United States | Details | |
USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
UC Davis Comprehensive Cancer Center LAPS | Sacramento | California | 95817 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
University of Chicago Comprehensive Cancer Center | Chicago | Illinois | 60637 | United States | Details | |
Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
Penn State Milton S Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | United States | Details | |
M D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |